| 000 | 00934 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513090048.0 | ||
| 264 | 0 | _c19960524 | |
| 008 | 199605s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/ajp.153.3.449a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFishbain, D A | |
| 245 | 0 | 0 |
_aFluoxetine and extrapyramidal side effects. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cMar 1996 |
||
| 300 |
_a449 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xepidemiology |
| 650 | 0 | 4 |
_aFluoxetine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 153 _gno. 3 _gp. 449 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/ajp.153.3.449a _zAvailable from publisher's website |
| 999 |
_c8609899 _d8609899 |
||